Affiliation:
1. Department of Radiology NYU Langone Health New York New York USA
2. Division of Biostatistics, Department of Population Health, Grossman School of Medicine NYU Langone Health New York New York USA
3. MR Application Predevelopment Siemens Healthcare GmbH Erlangen Germany
4. Digital Technology and Innovation Siemens Healthineers Princeton New Jersey USA
5. MR R&D Collaborations Siemens Medical Solutions USA New York New York USA
6. Digital and Automation Siemens Healthcare Erlangen Germany
Abstract
BackgroundDemand for prostate MRI is increasing, but scan times remain long even in abbreviated biparametric MRIs (bpMRI). Deep learning can be leveraged to accelerate T2‐weighted imaging (T2WI).PurposeTo compare conventional bpMRIs (CL‐bpMRI) with bpMRIs including a deep learning‐accelerated T2WI (DL‐bpMRI) in diagnosing prostate cancer.Study TypeRetrospective.PopulationEighty consecutive men, mean age 66 years (47–84) with suspected prostate cancer or prostate cancer on active surveillance who had a prostate MRI from December 28, 2020 to April 28, 2021 were included. Follow‐up included prostate biopsy or stability of prostate‐specific antigen (PSA) for 1 year.Field Strength and SequencesA 3 T MRI. Conventional axial and coronal T2 turbo spin echo (CL‐T2), 3‐fold deep learning‐accelerated axial and coronal T2‐weighted sequence (DL‐T2), diffusion weighted imaging (DWI) with b = 50 sec/mm2, 1000 sec/mm2, calculated b = 1500 sec/mm2.AssessmentCL‐bpMRI and DL‐bpMRI including the same conventional diffusion‐weighted imaging (DWI) were presented to three radiologists (blinded to acquisition method) and to a deep learning computer‐assisted detection algorithm (DL‐CAD). The readers evaluated image quality using a 4‐point Likert scale (1 = nondiagnostic, 4 = excellent) and graded lesions using Prostate Imaging Reporting and Data System (PI‐RADS) v2.1. DL‐CAD identified and assigned lesions of PI‐RADS 3 or greater.Statistical TestsQuality metrics were compared using Wilcoxon signed rank test, and area under the receiver operating characteristic curve (AUC) were compared using Delong's test. Significance: P = 0.05.ResultsEighty men were included (age: 66 ± 9 years; 17/80 clinically significant prostate cancer). Overall image quality results by the three readers (CL‐T2, DL‐T2) are reader 1: 3.72 ± 0.53, 3.89 ± 0.39 (P = 0.99); reader 2: 3.33 ± 0.82, 3.31 ± 0.74 (P = 0.49); reader 3: 3.67 ± 0.63, 3.51 ± 0.62. In the patient‐based analysis, the reader results of AUC are (CL‐bpMRI, DL‐bpMRI): reader 1: 0.77, 0.78 (P = 0.98), reader 2: 0.65, 0.66 (P = 0.99), reader 3: 0.57, 0.60 (P = 0.52). Diagnostic statistics from DL‐CAD (CL‐bpMRI, DL‐bpMRI) are sensitivity (0.71, 0.71, P = 1.00), specificity (0.59, 0.44, P = 0.05), positive predictive value (0.23, 0.24, P = 0.25), negative predictive value (0.88, 0.88, P = 0.48).ConclusionDeep learning‐accelerated T2‐weighted imaging may potentially be used to decrease acquisition time for bpMRI.Evidence Level3.Technical EfficacyStage 2.
Subject
Radiology, Nuclear Medicine and imaging